The IMS Institute is now the
for Human Data Science
- Institute
- Reports
- Improving Type-2 Diabetes Therapy Adherence and Persistence in Turkey
- The Growing Value of Digital Health
- The Growing Value of Digital Health in the United Kingdom
- Orphan Drugs in the United States
- Understand the Drivers of Drug Expenditure in the U.S.
- 2018 and Beyond Outlook and Turning Points
- Medicine Use and Spending in the US Review of 2017 Outlook to 2022
- Understanding the Dynamics of Drug Expenditure
- Economic Implications of Improving Type 2 Diabetes Management in China
- Global Oncology Trends 2017
- Upholding the Clinical Promise of Precision Medicine
- Medicines Use and Spending in the U.S.
- Lifetime Trends in Biopharmaceutical Innovation
- Reports Archive

Stay connected to the IQVIA Institute for publication updates.
Reports
Featured Report
Medicine Use and Spending in the U.S. A Review of 2017 and an Outlook to 2022
Spending on medicines remains a topic of intense interest among policy makers, patients, payers and drug manufacturers. This report focuses its attention on “net spending” on medicines in the United States in 2017 with an outlook to 2022, explores out-of-pocket patient costs at pharmacies and examines the overall volume of medicines being used, with a special focus of opioids and newly launched, innovative medicines.